Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Inhibition of Mammalian Mitochondrial Protein Synthesis by OxazolidinonesIn Vitro Study · 2006 · 271 citations
2. 2Linezolid for Treatment of Chronic Extensively Drug-Resistant TuberculosisHuman Clinical Trial · 2012 · 561 citations
3. 3Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine TuberculosisEarly-Phase Clinical Trial · 2009 · 124 citations
4. 4Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for TuberculosisOriginal Research · 2010 · 127 citations
5. 5Pharmacokinetics and Whole‐Blood Bactericidal Activity against<i>Mycobacterium tuberculosis</i>of Single Doses of PNU‐100480 in Healthy VolunteersOriginal Research · 2010 · 103 citations